Skip to content
Clinical Trials – home
Therapeutic area

Injury, poisoning and procedural complications – page 12

  • 286 clinical trials
  • 125 recruiting
  • 217 conditions
  • 25 countries

Conditions in this area

217 conditions with trials, the busiest first

Clinical trials in Injury, poisoning and procedural complications

286 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

286 clinical trials

Cartilage injury

Not yet recruiting

Non‑inferiority study of autologous minced cartilage and autologous cultured chondrocytes in adults with large full‑thickness knee cartilage defects

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Sponsor:Medical Center - University Of Freiburg

Fracture infection

Not yet recruiting

Supplementary Oxygen Therapy for Patients with Fracture-Related Infection After Limb Debridement and Reconstruction Surgery: A Pilot Randomized Trial

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Oxygen
  • Sponsor:Amsterdam UMC Stichting

Retinopathy of prematurity

Not yet recruiting

Intranasal Dexmedetomidine for Pain Relief During Retinopathy of Prematurity Screening in Preterm Infants <30 Weeks Gestation Using Standard Drug Combination

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Dexmedetomidine
  • Sponsor:St. Olavs Hospital HF

Craniocerebral injury

Not yet recruiting

Safety and Efficacy of AST-004 in Patients with Mild Complicated Traumatic Brain Injury

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years

Kidney transplant rejection

Not yet recruiting

Evaluation of zirconium-89 crefmirlimab berdoxam PET imaging for monitoring renal allograft rejection in kidney transplant recipients

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Zirconium (89Zr) Crefmirlimab Berdoxam
  • Sponsor:Stichting Radboud University Medical Center

Subarachnoid haemorrhage

Not yet recruiting

Ticagrelor versus placebo to prevent cerebral ischemia in patients with low‑grade aneurysmal subarachnoid hemorrhage

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ticagrelor
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Skin wound

Not yet recruiting

Verteporfin for Scar Prevention in Patients After Surgical Wounds

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Saline
  • Sponsor:Odense University Hospital

Graft versus host disease

Not yet recruiting

A study to evaluate the effectiveness of MC0518 (mesenchymal stromal cells) in adults with acute graft-versus-host disease that has not responded to steroids and ruxolitinib

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Mesenchymal Stromal Cells, Ex Vivo Cultured
  • Sponsor:Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia

A study to evaluate the effectiveness of ispaghula husk in patients with low anterior resection syndrome after rectal cancer surgery

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:ISPAGHULA HUSK

Hypoparathyroidism

Not yet recruiting

Study evaluating the effects of palopegteriparatide and alfacalcidol on quality of life and brain function in patients with hypoparathyroidism

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alfacalcidol
  • Sponsor:Region Midtjylland

Graft versus host disease

Not yet recruiting

Safety and Efficacy of MaaT013 with Vancomycin in Children and Adolescents with Gastrointestinal Acute Graft‑versus‑Host Disease

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Vancomycin
  • Sponsor:Maat Pharma

Effect of Dexmedetomidine vs Sodium Chloride on Emergence Delirium in Children Aged 1‑7 Years Undergoing Adenotonsillectomy

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Dexmedetomidine
  • Sponsor:Akershus University Hospital

Substances studied in this area

The therapies tested most often in Injury, poisoning and procedural complications trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.